Markets

Tuesday 1/24 Insider Buying Report: MCC, HRTX

Shutterstock photo
Shutterstock photo

Shutterstock photo

As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys.

On Monday, Medley Capital Corporation ( MCC )'s Director, Seth Taube, made a $499,345 purchase of MCC, buying 66,585 shares at a cost of $7.50 each. So far Taube is in the green, up about 2.4% on their purchase based on today's trading high of $7.68. Medley Capital Corporation is trading up about 2% on the day Tuesday. Before this latest buy, Taube purchased MCC at 17 other times during the past year, for a total investment of $17.45M at an average of $7.38 per share.

And on Thursday, Director John Poyhonen purchased $122,000 worth of Heron Therapeutics ( HRTX ), purchasing 10,000 shares at a cost of $12.20 each. This buy marks the first one filed by Poyhonen in the past year. Heron Therapeutics is trading off about 1.2% on the day Tuesday. So far Poyhonen is in the green, up about 6.1% on their purchase based on today's trading high of $12.95.

VIDEO: Tuesday 1/24 Insider Buying Report: MCC, HRTX

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

HRTX MCC

Latest Markets Videos

    BNK Invest

    BNK Invest Inc. provides investment services and information. BNK Invest owns and operates a market news family of websites including DividendChannel, ETFChannel, StockOptionsChannel, and others, which make up an investor community featuring stock message boards, ratings, research, and strategies. BNK Invest caters to investing firms and individual investors internationally.

    Learn More